Measuring medication - Do interviews agree with medical record and pharmacy data?

被引:22
作者
Korthuis, PT
Asch, S
Mancewicz, M
Shapiro, MF
Mathews, WC
Cunningham, WE
McCutchan, JA
Gifford, A
Lee, ML
Bozzette, SA
机构
[1] Univ Calif Los Angeles, Greater Los Angeles VA Syst, Los Angeles, CA 90073 USA
[2] RAND Corp, Hlth Program, Santa Monica, CA 90407 USA
[3] Univ Calif San Diego, San Diego, CA 92103 USA
[4] San Diego VA Hlth Care Syst, San Diego, CA USA
[5] Ctr Study Healthcare Provider Behav, Sepulveda, CA USA
关键词
HIV disease/AIDS; medications; cohort studies; methodology; epidemiology;
D O I
10.1097/01.MLR.0000036406.61316.B5
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
BACKGROUND. Medication measurement is crucial in assessing quality for chronic conditions yet agreement of alternate data sources remains uncertain. OBJECTIVES. To evaluate medication agreement between interviews, medical records, and pharmacy data; to assess data source contribution to attributing medication exposure; and to describe the impact of combining data sources on models that predict medication use. RESEARCH DESIGN. Prospective cohort study. SUBJECTS. Probability sample of HIV infected participants in the HIV Cost and Services Utilization Study. MEASURES. Medications reported in 2267 interviews, 1936 medical records, and 457 pharmacy records were compared using crude agreement, kappa, and the proportion of average positive and negative agreement. The percent of medications reported in each source alone was used to assess their relative contri- bution to attributing exposure status. We performed weighted logistic regression in alternate data sources. RESULTS. Kappa varied from 0.38 for nucleoside reverse transcriptase inhibitors to 0.70 for protease inhibitors, when comparing drug classes in interview versus medical record, interview versus pharmacy data, and medical record versus pharmacy data. The percentage of medications reported in medical records was greater than that reported in interviews or pharmacy data. Pharmacy data contributed little to the attribution of medication exposure. Adding medication data to interview data did not appreciably change analytic models predicting medication use. combining data sources does not change the results of analytic models predicting appropriate medication use.CONCLUSIONS. For specific medications, agreement between alternative data sources is fair to substantial, but is lower for key drug classes. Relying on one data source may lead to misclassification of drug exposure status, but combining data sources does not change the results of analytic models predicting appropriate medication use.
引用
收藏
页码:1270 / 1282
页数:13
相关论文
共 33 条
[1]  
AGRESTI A, 1990, CATEGORICAL DATA ANA, P391
[2]  
Andersen R, 2000, HEALTH SERV RES, V35, P389
[3]   INCIDENCE OF ADVERSE DRUG EVENTS AND POTENTIAL ADVERSE DRUG EVENTS - IMPLICATIONS FOR PREVENTION [J].
BATES, DW ;
CULLEN, DJ ;
LAIRD, N ;
PETERSEN, LA ;
SMALL, SD ;
SERVI, D ;
LAFFEL, G ;
SWEITZER, BJ ;
SHEA, BF ;
HALLISEY, R ;
VANDERVLIET, M ;
NEMESKAL, R ;
LEAPE, LL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (01) :29-34
[4]  
BERRY SH, 1998, MR1090AHCPR RAND
[5]   INCIDENCE OF ADVERSE EVENTS AND NEGLIGENCE IN HOSPITALIZED-PATIENTS - RESULTS OF THE HARVARD MEDICAL-PRACTICE STUDY-I [J].
BRENNAN, TA ;
LEAPE, LL ;
LAIRD, NM ;
HEBERT, L ;
LOCALIO, AR ;
LAWTHERS, AG ;
NEWHOUSE, JP ;
WEILER, PC ;
HIATT, HH .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (06) :370-376
[6]   QUALITY-OF-CARE ASSESSMENT - CHOOSING A METHOD FOR PEER REVIEW [J].
BROOK, RH ;
APPEL, FA .
NEW ENGLAND JOURNAL OF MEDICINE, 1973, 288 (25) :1323-1329
[7]  
*CDCP, 1998, MMWR-MORBID MORTAL W, V47, P43
[8]   HIGH AGREEMENT BUT LOW KAPPA .2. RESOLVING THE PARADOXES [J].
CICCHETTI, DV ;
FEINSTEIN, AR .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1990, 43 (06) :551-558
[9]   Comparison of self reported and physician reported antidepressant medication use [J].
Cotterchio, M ;
Kreiger, N ;
Darlington, G ;
Steingart, A .
ANNALS OF EPIDEMIOLOGY, 1999, 9 (05) :283-289
[10]   Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the United States [J].
Cunningham, WE ;
Markson, LE ;
Andersen, RM ;
Crystal, SH ;
Fleishman, JA ;
Golin, C ;
Gifford, A ;
Liu, HHH ;
Nakazono, TT ;
Morton, S ;
Bozzette, SA ;
Shapiro, MF ;
Wenger, NS .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 25 (02) :115-123